Teva Maintains Innocence After DoJ Price Fixing Charge

Consumers Allegedly Overcharged By $350m

Teva has insisted it “did not participate in price fixing,” after being charged by the US Department of Justice with conspiring to fix prices for generic medicines, resulting in consumers being “allegedly overcharged at least $350m.”

Washington DC, USA-June 5, 2018: Robert F Kennedy Department of Justice building entrance "The Place of Justice is a Hallowed Place" engraved in stone above the door
Teva has "firmly rejected" the DoJ's allegations • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin